Hamilton rating scale for depression-24 (HAM-D24) as a novel predictor for diabetic microvascular complications in type 2 diabetes mellitus patients

被引:30
|
作者
Pan, Shuo [1 ]
Liu, Zhong-Wei [1 ]
Shi, Shuang [1 ]
Ma, Xun [2 ]
Song, Wen-Qian [3 ]
Guan, Gong-Chang [1 ]
Zhang, Yong [1 ]
Zhu, Shun-Ming [1 ]
Liu, Fu-Qiang [1 ]
Liu, Bo [1 ]
Tang, Zhi-Guo [1 ]
Wang, Jun-Kui [1 ]
Lv, Ying [1 ]
机构
[1] Peoples Hosp Shaanxi Prov, Dept Cardiol 1, Xian, Shaanxi, Peoples R China
[2] Peoples Hosp Shaanxi Prov, Dept Emergency Med, Xian, Shaanxi, Peoples R China
[3] Northwest Univ, Univ Hosp, Dept Internal Med, Xian, Shaanxi, Peoples R China
关键词
Hamilton rating scale for depression; Diabetic complications; Microvascular; Type 2 diabetes mellitus; QUALITY-OF-LIFE; COMORBID DEPRESSION; DISEASE SEVERITY; FOOT ULCERS; SELF-CARE; ASSOCIATION; PREVALENCE; HEALTH; SYMPTOMS; ADULTS;
D O I
10.1016/j.psychres.2017.07.050
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The study was designed to investigate whether the hamilton rating scale for depression (24-items) (HAM-D-24) can be used to predict the diabetic microvascular complications in type 2 diabetes mellitus (T2DM) patients. 288 hospitalized patients with T2DM were enrolled. Their diabetic microvascular complications including diabetic nephropathy, diabetic retinopathy, diabetic peripheral neuropathy and diabetic foot as well as demographic, clinical data, blood samples and echocardiography were documented. All the enrolled patients received HAM D-24 evaluation. The HAM-D-24 score and incidence of depression in T2DM patients with each diabetic micro vascular complication were significantly higher than those in T2DM patients without each diabetic micro vascular complication. After the adjustment of use of insulin and hypoglycemic drug, duration of T2DM, mean platelet volume, creatinine, albumin, fasting glucose, glycosylated hemoglobin type A1C, left ventricular ejection fraction, respectively, HAM-D-24 score was still significantly associated with diabetic microvascular complications (OR = 1.188-1.281, all P < 0.001). The AUC of HAM-D-24 score for the prediction of diabetic microvascular complication was 0.832 (0.761-0.902). 15 points of HAM-D-24 score was considered as the optimal cutoff with the sensitivity of 0.778 and specificity of 0.785. In summary, HAM-D-24 score may be used as a novel predictor of diabetic microvascular complications in T2DM patients.
引用
收藏
页码:177 / 183
页数:7
相关论文
共 8 条
  • [1] Frequency of Depression in Patients with Type 2 Diabetes Mellitus and its Relationship with Glycemic Control and Diabetic Microvascular Complications
    Sharif, Sabira
    Raza, Muhammad T.
    Mushtaq, Samsam
    Afreen, Bahjat
    Hashmi, Bushra Azam
    Ali, Muhammad Hassaan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
  • [2] Relationship of serum vitamin D levels with diabetic microvascular complications in patients with type 2 diabetes mellitus
    Zhao, Wei-Jing
    Xia, Xin-Yi
    Yin, Jun
    CHINESE MEDICAL JOURNAL, 2021, 134 (07) : 814 - 820
  • [3] Relationship between dietary patterns and diabetic microvascular complications in patients with type 2 diabetes mellitus
    Liu, Y. -J.
    Wang, Y.
    Xu, L. -X.
    Yang, J.
    Zhao, Y.
    Qiao, J.
    Li, N.
    Li, Y.
    Lv, D. -Q.
    Sun, W. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (18) : 8780 - 8794
  • [4] Validation of the turkish version of the centre for epidemiologic studies depression scale (ces-d) in patients with type 2 diabetes mellitus
    Lehmann, Vicky
    Makine, Ceylan
    Karsidag, Cagatay
    Kadioglu, Pinar
    Karsidag, Kubilay
    Pouwer, Francois
    BMC MEDICAL RESEARCH METHODOLOGY, 2011, 11
  • [5] The association between 25-hydroxy vitamin D deficiency and diabetic complications in patients with type 2 diabetes mellitus
    Senyigit, Abdulhalim
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (02) : 1381 - 1386
  • [6] Novel indicator of microvascular complications in patients with type 2 diabetes mellitus and shortened erythrocyte lifespan: a multicenter cross-sectional analysis
    Wu, Yunqi
    Zhang, Binshan
    Ma, Xin
    Yu, Pei
    Zhou, Saijun
    Wang, Xinli
    DIABETOLOGY & METABOLIC SYNDROME, 2025, 17 (01)
  • [7] Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-on Lantus® to Oral Hypoglycemic Agents (ALOHA) study
    Odawara, Masato
    Kadowaki, Takashi
    Naito, Yusuke
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (01) : 127 - 133
  • [8] Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial
    Hong, S.
    Park, C. -Y.
    Han, K. A.
    Chung, C. H.
    Ku, B. J.
    Jang, H. C.
    Ahn, C. W.
    Lee, M. -K.
    Moon, M. K.
    Son, H. S.
    Lee, C. B.
    Cho, Y. -W.
    Park, S. -W.
    DIABETES OBESITY & METABOLISM, 2016, 18 (05) : 528 - 532